Evidence map›Paper›PMID 23534985›Full record

ArticleBioconjugate chemistry2013

Facile and stabile linkages through tyrosine: bioconjugation strategies with the tyrosine-click reaction.

Hitoshi Ban, Masanobu Nagano, Julia Gavrilyuk, Wataru Hakamata, Tsubasa Inokuma, Carlos F Barbas

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 194 citations in OpenAlex.

  1. Article
  2. B(COrganic letters · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Chemical Tagging ofJournal of the American Chemical Society · 2025
    Article
  8. Article
  9. Methods for Conjugating Antibodies with Quantum Dots.Molecules (Basel, Switzerland) · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. X-Ray Visible Protein Scaffolds by Bulk Iodination.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  15. Enlarging the scenario of site directedScientific reports · 2023
    Article
  16. Recent Advances of S-ACS omega · 2023
    Review
  17. Review
  18. ACS central science · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hitoshi BanThe Skaggs Institute for Chemical Biology and the Departments of Chemistry and Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Masanobu Nagano
Julia Gavrilyuk
Wataru Hakamata
Tsubasa Inokuma
Carlos F Barbas
Scripps Research Institute · US

Funding

Chemically Programmed ImmunityDP1CA174426 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI DAWSON, PHILIP E · 2012 to 2014
$2.3M
Chemically Programmed ImmunityDP1OD006990 · OD · SCRIPPS RESEARCH INSTITUTE, THE · PI BARBAS, CARLOS F · 2010 to 2011
$1.9M
Multifunctional Human Anti-HIV AntibodiesR01AI095038 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BURTON, DENNIS R. · 2011 to 2014
$1.9M
NCI NIH HHS DP1 CA174426NIAID NIH HHS R01 AI095038NIH HHS DP1 OD006990
6 · The paper itself

Abstract

The scope, chemoselectivity, and utility of the click-like tyrosine labeling reaction with 4-phenyl-3H-1,2,4-triazoline-3,5(4H)-diones (PTADs) is reported. To study the utility and chemoselectivity of PTAD derivatives in peptide and protein chemistry, we synthesized PTAD derivatives possessing azide, alkyne, and ketone groups and studied their reactions with amino acid derivatives and peptides of increasing complexity. With proteins we studied the compatibility of the tyrosine click reaction with cysteine and lysine-targeted labeling approaches and demonstrate that chemoselective trifunctionalization of proteins is readily achieved. In particular cases, we noted that PTAD decomposition resulted in formation of a putative isocyanate byproduct that was promiscuous in labeling. This side reaction product, however, was readily scavenged by the addition of a small amount of 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris) to the reaction medium. To study the potential of the tyrosine click reaction to introduce poly(ethylene glycol) chains onto proteins (PEGylation), we demonstrate that this novel reagent provides for the selective PEGylation of chymotrypsinogen, whereas traditional succinimide-based PEGylation targeting lysine residues provided a more diverse range of PEGylated products. Finally, we applied the tyrosine click reaction to create a novel antibody-drug conjugate. For this purpose, we synthesized a PTAD derivative linked to the HIV entry inhibitor aplaviroc. Labeling of the antibody trastuzumab with this reagent provided a labeled antibody conjugate that demonstrated potent HIV-1 neutralization activity demonstrating the potential of this reaction in creating protein conjugates with small molecules. The tyrosine click linkage demonstrated stability to extremes of pH, temperature, and exposure to human blood plasma indicating that this linkage is significantly more robust than maleimide-type linkages that are commonly employed in bioconjugations. These studies support the broad utility of this reaction in the chemoselective modification of small molecules, peptides, and proteins under mild aqueous conditions over a broad pH range using a wide variety of biologically acceptable buffers such as phosphate buffered saline (PBS) and 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris) buffers as well as others and mixed buffered compositions.

Indexed as

Click ChemistryHumansHydrogen-Ion ConcentrationModels, MolecularMolecular StructurePolyethylene GlycolsTemperatureTriazolesTyrosine4-phenyl-1,2,4-triazoline-3,5-dionePolyethylene GlycolsTriazolesTyrosine

Identifiers

PMID23534985
PMCPMC3658467
OpenAlexW2325516935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.